Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member., Inc. (CRM) Stock Is Going Nowhere. Here’s Why.

Page 1 of 2

In a buoyant, bullish stock market, it’s been pretty strange to watch how the tech-heavy Nasdaq Composite Index has underperformed the Dow Jones Industrial Average (INDEXDJX:.DJI) by more than a full percentage point since the year began. One tech stock in particular that’s been failing to pull its weight is, inc. (NYSE:CRM) , whose stock has lost a percentage point’s worth of market cap since early January. But why?

Three reasons., inc. (NYSE:CRM)

Salesforce stock is all bark …
When you stack up, inc. (NYSE:CRM) stock against two of its larger, incumbent rivals in database software — SAP AG (NYSE:SAP) and Oracle Corporation (NASDAQ:ORCL) — there’s plenty of reason to expect the former to outperform the latter. For example, according to the smart folks at, who keep track of these kinds of things, Salesforce boasts a better record of sales growth than either of its rivals:, Inc. (CRM) Stock Is Going Nowhere. Here's Why.

With a historical sales-growth rate more than twice that of Oracle Corporation (NASDAQ:ORCL), and more than three times SAP AG (NYSE:SAP)’s plodding pace of 9.6% growth,, inc. (NYSE:CRM) stock should be running away from its rivals. And it is … sort of. Both Oracle and SAP shares are down more than Salesforce since the year began, so Salesforce is outperforming the competition — yet the stock’s still not growing by the leaps and bounds that you might expect a 32% growth rate to produce.

Salesforce stock is also expected to turn in stronger earnings growth than either SAP AG (NYSE:SAP) or Oracle Corporation (NASDAQ:ORCL) over the next five years:

Yet once again, despite its boasting both strong past performance and strong future prospects, investors continue to treat, inc. (NYSE:CRM) stock like a dog with fleas.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!